While its "AAA" credit rating, robust free cash flow, and low-debt profile offer a defensive haven in a volatile market, the ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The fair value estimate for Johnson & Johnson has been adjusted from US$232.50 ...

Johnson & Johnson’s position as a diversified healthcare leader continues to attract attention within equity markets. Through ...

With a market cap of $592.4 billion, New Brunswick, New Jersey-based Johnson & Johnson (JNJ)is a global healthcare company engaged in the research, development, manufacturing, and sale of a broad ...

Johnson & Johnson reported impressive fourth-quarter results that beat expectations while outlining an aggressive growth strategy. And here's something investors might find appealing: Johnson & ...

Johnson & Johnson (JNJ) grew its Q4 2025 sales by 9.1% to $24.6 billion. Apple (AAPL) recently reported a “record-breaking quarter” with “unprecedented demand” for iPhones. Bank of America (BAC) is a ...

Tue, December 2, 2025 at 8:46 PM UTC The motivation is the general uncertainty about what the next few months may bring. The Federal Reserve is continuing interest rate cuts, and is expected to cut ...

Hindsight is always 20/20, and nowhere is this more evident than in the stock market. But that doesn’t stop investors from trying to determine what they would have made if they had actually invested ...

Johnson & Johnson (NYSE:JNJ) is one of the best stocks that will always grow. Johnson & Johnson (NYSE:JNJ) announced on March 5 that the U.S. Food and Drug Administration (FDA) granted approval for ...